InvestorsHub Logo
Followers 23
Posts 2554
Boards Moderated 0
Alias Born 12/24/2009

Re: None

Tuesday, 03/09/2010 9:10:03 AM

Tuesday, March 09, 2010 9:10:03 AM

Post# of 105534
News Out.

Cord Blood America's New Medical Director Says Parkinson's, Diabetes Among Diseases to be Treated With Umbilical Cord Blood Stem Cells
8:55a ET March 9, 2010 (PR NewsWire)
Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com), is focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally. Its new Director of the Medical Advisory Board, Shamoon Ahmad, M.D., M.B.A., FACP, was interviewed about the stem cell revolution in medical care by analyst Francis Gaskins.

The entire interview is available at http://gaskinsco.com/cbai-3-8-10-b.mp3 .

Dr. Ahmad said he believes that stem cells preserved from the umbilical cord at birth will be used to treat Parkinson's disease, diabetes and muscular sclerosis, among other chronic diseases, which, he said, are amenable to cord blood transplants. Currently more than 70 diseases, including childhood leukemia and sickle cell anemia, are treated with these preserved stem cells.

The interview also features information about Dr. Ahmad's background, including that he established the first, and only, bone marrow transplantation facility in Nevada. He also is a registered investigator with the National Cancer Institute.

Dr. Ahmad explained that his new position means he will oversee the medical requirements of Cord Blood America's program and its quality. "We are looking for innovation," Dr. Ahmad said, explaining that the Company is a pioneer in stem cell storage and will soon add other biologic storage and preservation at its new Las Vegas facility

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.